Recent advances in dengue: Relevance to Puerto Rico

Puerto Rico Health Sciences Journal

Volumn 34, Issue 2, 2015, Pages 65-70

  Noyd, David H ^a   Sharp, Tyler M ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Dengue; Epidemiology; Public Health

Indexed keywords

DENGUE; EPIDEMIOLOGICAL MONITORING; HUMAN; PUERTO RICO;

DENGUE; EPIDEMIOLOGICAL MONITORING; HUMANS; PUERTO RICO;

EID: 84930404113     PISSN: 07380658     EISSN: 23736011     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. World Health Organization, Special Programme for Research and Training in Tropical Diseases. Dengue : Guidelines for diagnosis, treatment, prevention, and control. Geneva, Switzerland: World Health Organization; 2009.
2. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013;496:504-507.
3. Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions: Time for a reassessment. Lancet 2006;368:170-173.
4. Bandyopadhyay S, Lum LCS, Kroeger A. Classifying dengue: A review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 2006;11:1238-1255.
5. Barniol J, Gaczkowski R, Barbato EV, et al. Usefulness and applicability of the revised dengue case classification by disease: Multi-centre study in 18 countries. BMC Infect Dis 2011;11:106.
6. Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: An historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 2013;158:1445-1459.
7. Wallace D, Canouet V, Garbes P, Wartel TA. Challenges in the clinical development of a dengue vaccine. Curr Opin Virol 2013;3:352-356.
8. Sabchareon A, Wallace D, Sirivichayakul C, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in thai schoolchildren: A randomised, controlled phase 2b trial. Lancet 2012;380:1559-1567.
9. Lam PK, Tam DTH, Diet TV, et al. Clinical characteristics of dengue shock syndrome in vietnamese children: A 10-year prospective study in a single hospital. Clin Infec Dis 2013;57:1577-1586.
10. Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC. Corticosteroids in the treatment of dengue shock syndrome. Infect Drug Resist 2014;7: 137-143.
11. Menon K, McNally D, Choong K, Sampson M. A systematic review and meta-analysis on the effect of steroids in pediatric shock. Pediatr Crit Care Med 2013;14:474-480.
12. Tapia-Conyer R, Méndez-Galván JF, Gallardo-Rincón H. The growing burden of dengue in Latin America. J Clin Virol 2009;46(Suppl 2): S3-S6.
13. Murray NEA, Quam MB, Wilder-Smith A. Epidemiology of dengue: Past, present and future prospects. Clin Epidemiol 2013;5:299-309.
14. Gubler DJ. Dengue, urbanization and globalization: The unholy trinity of the 21st century. Trop Med Health 2011;39(4 Suppl):3-11.
15. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002;10:100-103.
16. Herrera-Martinez AD, Rodríguez-Morales AJ. Potential influence of climate variability on dengue incidence registered in a western pediatric hospital of Venezuela. Trop Biomed 2010;27:280-286.
17. Guzman MG, Halstead SB, Artsob H, et al. Dengue: A continuing global threat. Nat Rev Microbiol 2010;8(12 Suppl):S7-16.
18. Jury MR. Climate influence on dengue epidemics in Puerto Rico. Int J Environ Health Res. 2008;18(5):323-334.
19. Johansson M, Cummings D, Glass G. Multiyear climate variability and dengue-El niño southern oscillation, weather, and dengue incidence in Puerto Rico, Mexico, and Thailand: A longitudinal data analysis. PLoS Med 2009;6:e1000168.
20. Morin CW, Comrie AC, Ernst K. Climate and dengue transmission: Evidence and implications. Environ Health Perspect 2013;121:1264-1272.
21. Brathwaite Dick O, San Martín JL, Montoya RH, et al. The history of dengue outbreaks in the Americas. Am J Trop Med Hyg 2012;87:584-593.
22. King W. The epidemic of dengue in Porto Rico:1915. New Orleans Med Surg J 1917;69:564-571.
23. Diaz-Rivera R. A bizarre type of seven day fever clinically indistinguishable from dengue. Bol Asoc Med P R 1946;38:75-80.
24. Ehrenkranz NJ, Ventura AK, Cuadrado RR, et al. Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems. N Engl J Med 1971;285:1460-1469.
25. Rigau-Pérez JG, Ayala-López A, García-Rivera EJ, et al. The reappearance of dengue-3 and a subsequent dengue-4 and dengue-1 epidemic in Puerto Rico in 1998. Am J Trop Med Hyg 2002;67:355-362.
26. Tomashek K, Rivera A, Muñoz-Jordan J, et al. Description of a large island-wide outbreak of dengue in Puerto Rico, 2007. Am J Trop Med Hyg 2009;81:467-474.
27. Sharp TM, Hunsperger E, Santiago GA, et al. Virus-specific differences in rates of disease during the 2010 dengue epidemic in Puerto Rico. PLoS Negl Trop Dis 2013;7:e2159.
28. Tomashek KM, Gregory CJ, Rivera Sánchez A, et al. Dengue deaths in Puerto Rico: Lessons learned from the 2007 epidemic. PLoS Negl Trop Dis 2012;6:e1614.
29. Likosky WH, Calisher CH, Michelson AL. An epidemiologic study of dengue type 2 in Puerto Rico, 1969. Am J Epidemiol 1973;97:264-275.
30. German RR, Lee, LM, Horan JM, et al.; Guidelines Working Group Centers for Disease Control and Prevention (CDC). Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 2001;50:1-35.
31. Runge-Ranzinger S, Horstick O, Marx M, Kroeger A. What does dengue disease surveillance contribute to predicting and detecting outbreaks and describing trends? Trop Med Int Health 2008;13:1022-1041.
32. Rigau-Pérez JG. Surveillance for an emerging disease: Dengue hemorrhagic fever in Puerto Rico, 1988-1997. Puerto Rico Association of Epidemiologists. P R Health Sci J 1999;18:337-345.
33. Dechant EJ, Rigau-Pérez JG. Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: Estimation by capture-recapture methods. Am J Trop Med Hyg 1999;61:574-578.
34. Ramos MM, Argüello DF, Luxemburger C, et al. Epidemiological and clinical observations on patients with dengue in Puerto Rico: Results from the first year of enhanced surveillance-June 2005-May 2006. Am J Trop Med Hyg 2008;79:123-127.
35. Tomashek K, Lorenzi-Peña O, Margolis H. Sentinel enhanced dengue surveillance in Puerto Rico: A proposal for establishment of the first sentinel site in the Ponce health region. 2011.
36. Andries A-C, Duong V, Ngan C, et al. Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG. PLoS Negl Trop Dis 2012;6:e1993.
37. Gan VC, Tan L-K, Lye DC, et al. Diagnosing dengue at the point-ofcare: Utility of a rapid combined diagnostic kit in Singapore. PLoS ONE 2014;9:90037.
38. Santiago GA, Vergne E, Quiles Y, et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis 2013;7:2311.
39. Namekar M, Ellis EM, O'Connell M, et al. Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection. J Clin Microbiol 2013;51:3102-3106.
40. Bruce MG, Sanders EJ, Leake JAD, et al. Leptospirosis among patients presenting with dengue-like illness in Puerto Rico. Acta Trop 2005;96: 36-46.
41. Sharp TM, Roth NM, Torres J, et al. Chikungunya cases identified through passive surveillance and household investigations-Puerto Rico, May 5-August 12, 2014. MMWR Morb Mortal Wkly Rep 2014;63: 1121-1128.
42. Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis 2009;9:200.
43. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health 2008;13:1328-1340.
44. Gregory CJ, Santiago LM, Argüello DF, et al. Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area--Puerto Rico, 2007-2008. Am J Trop Med Hyg 2010;82:922-929.
45. Lorenzi OD, Gregory CJ, Santiago LM, et al. Acute febrile illness surveillance in a tertiary hospital emergency department: Comparison of influenza and dengue virus infections. Am J Trop Med Hyg 2013;88: 472-480.
46. Tomashek KM, Gregory CJ, Rivera Sánchez A, et al. Dengue deaths in Puerto Rico: Lessons learned from the 2007 epidemic. PLoS Negl Trop Dis 2012;6:1614.
47. World Health Organization. WHO global strategy for dengue prevention and control, 2012-2020. Geneva, Switzerland; 2012.
48. Capeding MR, Tran NH, Hadinegoro SRS, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 2014;384:1358-1365.
49. Wilder-Smith A. Dengue vaccines: Dawning at last? Lancet 2014;384:1327-1329.
50. Norrby R. Outlook for a dengue vaccine. Clin Microbiol Infect 2014;20(Suppl 5):92-94.